{
  "image_filename": "table_p4_det_3_003.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p4_det_3_003.png",
  "image_type": "Table",
  "page_number": 4,
  "block_id": "det_3_003",
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "supports_claim": false,
  "explanation": "A table showing pre\u2010 and post\u2010vaccination geometric mean titers (with 95% confidence intervals) and percentage seroresponse (4\u2010fold rise to \u22651:40) for placebo, Flublok, previously vaccinated Flublok subgroup, and non-previously vaccinated Flublok subgroup across three influenza strains. does not support the claim: the table presents immunogenicity outcomes but provides no information on the antigen content of Flublok versus standard\u2010dose vaccines, and no 3\u00d7 HA dose comparison is shown. Note: None",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table showing pre\u2010 and post\u2010vaccination geometric mean titers (with 95% confidence intervals) and percentage seroresponse (4\u2010fold rise to \u22651:40) for placebo, Flublok, previously vaccinated Flublok subgroup, and non-previously vaccinated Flublok subgroup across three influenza strains.",
    "evidence_found": null,
    "reasoning": "does not support the claim: the table presents immunogenicity outcomes but provides no information on the antigen content of Flublok versus standard\u2010dose vaccines, and no 3\u00d7 HA dose comparison is shown.",
    "confidence_notes": "None"
  }
}